Verrica Pharmaceuticals Inc. (VRCA) stock
VRCANasdaqPharmaceutical PreparationsFiscal year ends December 31
$3.56−0.16 (-4.30%)
Close on Nov 13, 2026Market cap $61.16MP/E –Yield –
Verrica Pharmaceuticals enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Verrica Pharmaceuticals's enterprise value was $55.97M on Nov 11, 2026, against $77.72M a year earlier. Over the last 5 years it ranged from $6.57M to $312.06M, with a median of $77.72M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $55.97M | -20.3% |
| 2025 | Dec 31, 2025 | $70.22M | +683.6% |
| 2024 | Dec 31, 2024 | $8.96M | -96.0% |
| 2023 | Dec 29, 2023 | $223.60M | +204.2% |
| 2022 | Dec 30, 2022 | $73.51M | -65.6% |
| 2021 | Dec 31, 2021 | $213.92M | -32.2% |
| 2020 | Dec 31, 2020 | $315.49M | -20.8% |
| 2019 | Dec 31, 2019 | $398.48M | +132.9% |
| 2018 | Dec 31, 2018 | $171.11M | – |
See a number that looks wrong?